已收盘 02-27 16:00:00 美东时间
0.000
NaN.00%
Companies Targeting Closing in Fourth Quarter of 2024Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), an innovation platform dedicated to accelerating promising health innovations, today announced that its
2024-09-24 20:34
As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (OTCQB:EVFM) is raising awareness of the potential impact these medications may have on the effectiveness of oral contraceptives. With an increasing number of wom...
2024-08-20 20:19